You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma, non-Hodgkin's

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin's, Adult Trial (SP-3164)

Not yet recruiting
  • Lymphoma, Non-Hodgkin's, Adult
  • (no location specified)
Aug 4, 2023

Non-hodgkin Lymphoma Trial (HY004)

Not yet recruiting
  • Non-hodgkin Lymphoma
  • HY004
  • (no location specified)
Aug 21, 2023

Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Stem cell infusion
  • +5 more
  • Saint Louis, Missouri
    Washington University
Jan 17, 2023

Non-Hodgkin Lymphoma Trial in Sohag (real time pcr)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • real time pcr
  • Sohag, Egypt
    Sohag University
Jun 27, 2023

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • (no location specified)
Nov 2, 2023

Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial (GEN3017)

Not yet recruiting
  • Classical Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma
  • GEN3017
  • (no location specified)
Aug 25, 2023

(CHANT)Real World Study of Duvelisib in Treatment of

Not yet recruiting
  • Follicular Lymphoma
  • +5 more
  • (no location specified)
Jun 20, 2023

Non-Hodgkin's Lymphoma and Hodgkin's Disease

Recruiting
  • Lymphoma, Non-Hodgkin
  • Hodgkin's Disease
    • Stanford, California
      Stanford University School of Medicine
    Sep 9, 2022

    CD20-positive B-cell Non-Hodgkin's Lymphoma Trial in Beijing (IMM0306)

    Recruiting
    • CD20-positive B-cell Non-Hodgkin's Lymphoma
    • Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Apr 6, 2023

    Lymphoma, Non-Hodgkin Trial in Perth (DZD8586)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • Perth, Western Australia, Australia
      Linear Clinical Research Ltd
    Apr 20, 2023

    Leukemia, Acute Lymphoblastic, Lymphoma, Non-Hodgkin Trial in Ribeirao Preto (CART-19)

    Not yet recruiting
    • Leukemia, Acute Lymphoblastic
    • Lymphoma, Non-Hodgkin
    • CART-19
    • Ribeirao Preto, Sao Paulo, Brazil
      Ribeirao Preto School of Medicine, University of Sao Paulo
    Oct 23, 2023

    Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory, Advanced Solid Tumor Trial (TR115)

    Not yet recruiting
    • Non-Hodgkin's Lymphoma, Relapsed
    • +2 more
    • (no location specified)
    Dec 6, 2022

    Living Conditions After Non-Hodgkin's Lymphoma in France

    Not yet recruiting
    • Non-hodgkin's Lymphoma
    • Data collection
    • Questionnaires
    • Dijon, France
      Chu Dijon Bourgogne
    Oct 13, 2022

    Lymphoma, Non-Hodgkin Trial (JNJ-87801493, JNJ-80948543, JNJ-75348780)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • (no location specified)
    Nov 15, 2023

    Non-hodgkin Lymphoma Trial (CD38-SADA:177Lu-DOTA Complex)

    Not yet recruiting
    • Non-hodgkin Lymphoma
    • CD38-SADA:177Lu-DOTA Complex
    • (no location specified)
    Aug 15, 2023

    Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Duarte, Hackensack, Houston (SIRPant-M, External-beam

    Not yet recruiting
    • Refractory Non-Hodgkin Lymphoma
    • Relapsed Non-Hodgkin Lymphoma
    • SIRPant-M
    • External-beam radiotherapy (XRT)
    • Duarte, California
    • +2 more
    Jul 21, 2023

    Social and Genetic Factors on Outcomes in Adolescent and Young

    Not yet recruiting
    • Hodgkin Lymphoma
    • Non-Hodgkin Lymphoma
    • Biospecimen Collection
    • +2 more
    • (no location specified)
    Aug 18, 2023

    Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in New York (Venetoclax, Tazemetostat)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • New York, New York
      Weill Cornell Medicine/NewYork-Presberteryian Hospital
    Jan 18, 2023

    Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

    Not yet recruiting
    • Non-hodgkin Lymphoma
    • +9 more
    • CD79b-19 CAR T cells
    • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 6, 2023

    Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor(CAR) T Cells)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Diffuse Large B Cell Lymphoma
    • CD19-targeted Chimeric Antigen Receptor(CAR) T Cells
    • Tianjin, Tianjin, China
      Tianjin Cancer Hospital
    Nov 19, 2023

    Lymphoma, Non-Hodgkin, Myeloma Multiple Trial (Connected scale "Body Comp Pro" from Withings)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • Myeloma Multiple
    • Connected scale "Body Comp Pro" from Withings
    • (no location specified)
    Nov 9, 2023

    Lymphoma, Non-Hodgkin Trial in China (DZD8586)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Beijing, Beijing, China
    • +5 more
    Apr 25, 2023

    B-cell Non Hodgkin Lymphoma Trial in Hanzhou (CB dualCAR-NK19/70)

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • CB dualCAR-NK19/70
    • Hanzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Dec 25, 2022

    Non Hodgkin Lymphoma Trial in New York, Clayton, Frankston (IPH6501)

    Not yet recruiting
    • Non Hodgkin Lymphoma
    • New York, New York
    • +2 more
    Oct 12, 2023

    B-cell Non Hodgkin Lymphoma Trial (Odronextamab, Loncastuximab tesirine, Rituximab)

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • (no location specified)
    Aug 7, 2023